Xu Han Selected Research

Peptides (Polypeptides)

11/2022	Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer.
1/2019	Characterization of YY1 OPB Peptide for its Anticancer Activity.
3/2018	Dual-channel fluorescence diagnosis of cancer cells/tissues assisted by OATP transporters and cysteine/glutathione.
9/2017	Biocompatible and blood-brain barrier permeable carbon dots for inhibition of Aβ fibrillation and toxicity, and BACE1 activity.
3/2017	A resorcinarene for inhibition of Aβ fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xu Han Research Topics

Disease

122	Neoplasms (Cancer) 05/2024 - 06/2007
51	Inflammation (Inflammations) 12/2023 - 11/2013
23	Breast Neoplasms (Breast Cancer) 01/2024 - 12/2010
20	Type 2 Diabetes Mellitus (MODY) 01/2024 - 10/2006
19	Infections 05/2024 - 10/2006
17	Neoplasm Metastasis (Metastasis) 11/2023 - 05/2015
17	Reperfusion Injury 05/2023 - 11/2013
14	Carcinogenesis 02/2024 - 10/2013
14	Fibrosis (Cirrhosis) 01/2024 - 07/2015
14	Lung Neoplasms (Lung Cancer) 10/2021 - 06/2013
13	Non-alcoholic Fatty Liver Disease 12/2023 - 12/2013
13	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2013
12	Body Weight (Weight, Body) 12/2023 - 08/2011
12	Liver Cirrhosis (Hepatic Cirrhosis) 09/2023 - 04/2015
10	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2011
10	Stomach Neoplasms (Stomach Cancer) 06/2023 - 05/2012
9	Insulin Resistance 01/2023 - 01/2013
9	Carcinoma (Carcinomatosis) 10/2021 - 06/2013
8	Hemorrhage 03/2024 - 02/2017
8	Cognitive Dysfunction 12/2023 - 01/2017
8	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2012
8	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 09/2010
8	Hypoxia (Hypoxemia) 01/2021 - 01/2015
7	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 02/2017
7	Necrosis 01/2024 - 12/2015
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 02/2015
6	Obesity 03/2024 - 01/2015
6	Atrial Fibrillation 12/2023 - 12/2017
6	Glioma (Gliomas) 10/2023 - 03/2012
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2023 - 10/2013
6	Ischemic Stroke 01/2023 - 11/2013
6	Atherosclerosis 01/2023 - 04/2008
6	Wounds and Injuries (Trauma) 10/2022 - 01/2017
6	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2015
5	Human Influenza (Influenza) 02/2024 - 02/2016
5	Liver Neoplasms (Liver Cancer) 07/2023 - 02/2016
5	Colonic Neoplasms (Colon Cancer) 07/2023 - 12/2012
5	Mitochondrial Diseases (Mitochondrial Disease) 07/2022 - 11/2017
5	Cerebral Infarction 01/2022 - 07/2014
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2017
5	Hyperglycemia 01/2021 - 01/2016
5	Brain Ischemia (Cerebral Ischemia) 01/2020 - 11/2013
5	Glioblastoma (Glioblastoma Multiforme) 06/2016 - 03/2012
4	COVID-19 12/2024 - 01/2021
4	Sepsis (Septicemia) 05/2024 - 02/2020
4	Disease Progression 01/2024 - 03/2023
4	Stroke (Strokes) 01/2023 - 07/2014
4	Myocardial Infarction 01/2023 - 01/2018

Drug/Important Bio-Agent (IBA)

51	dioscinIBA 06/2023 - 08/2013
48	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2012
37	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2013
17	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2013
17	LipidsIBA 03/2024 - 09/2013
17	CytokinesIBA 05/2023 - 03/2014
14	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2015
14	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
11	Triglycerides (Triacylglycerol)IBA 05/2023 - 01/2013
11	MicroRNAs (MicroRNA)IBA 01/2023 - 03/2012
10	CholesterolIBA 05/2023 - 03/2014
9	Long Noncoding RNAIBA 02/2024 - 02/2015
9	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2015
9	Blood Glucose (Blood Sugar)IBA 12/2023 - 12/2014
8	FlavonoidsIBA 12/2019 - 11/2013
8	Small Interfering RNA (siRNA)IBA 07/2019 - 01/2015
7	oxidized low density lipoproteinIBA 01/2024 - 01/2016
6	Sirtuin 1IBA 12/2023 - 02/2016
6	HMGB1 Protein (HMG1)IBA 01/2023 - 01/2017
6	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 01/2018
6	LipopolysaccharidesIBA 05/2022 - 12/2015
5	Adenosine Triphosphate (ATP)IBA 01/2023 - 06/2016
5	Estrogen ReceptorsIBA 01/2023 - 10/2017
5	BilirubinIBA 01/2023 - 09/2016
5	Peptides (Polypeptides)IBA 11/2022 - 03/2017
5	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2022 - 01/2017
5	Hormones (Hormone)IBA 04/2022 - 10/2012
5	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2021 - 09/2013
5	Alanine Transaminase (SGPT)IBA 09/2021 - 03/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2008
5	Phosphotransferases (Kinase)IBA 10/2019 - 07/2016
4	CateninsIBA 01/2024 - 01/2014
4	HDL CholesterolIBA 01/2024 - 01/2016
4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
4	Warfarin (Coumadin)FDA LinkGeneric 12/2023 - 02/2017
4	Neuroprotective AgentsIBA 10/2023 - 11/2013
4	Uric Acid (Urate)IBA 07/2023 - 01/2015
4	AcidsIBA 07/2023 - 10/2008
4	Therapeutic UsesIBA 07/2023 - 01/2020
4	Caspase 3 (Caspase-3)IBA 07/2023 - 10/2017
4	CollagenIBA 03/2023 - 12/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 07/2016
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 05/2016
4	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2017
4	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 12/2010
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2013

Therapy/Procedure

43	Therapeutics 05/2024 - 06/2005
14	Drug Therapy (Chemotherapy) 01/2024 - 01/2011
7	Immunotherapy 01/2024 - 01/2020
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 12/2016
4	Radiotherapy 01/2024 - 06/2021